Muna A. AlShams
Anti-cancer activity of some new Isatin derivatives as apoptosis inducers through kinase inhibition signaling pathway
In this study, an efficient click synthesis has been employed to combine isatin, Schiff base, and 1,2,3-triazole in a single framework. Propargylation of 5-bromoisatin, followed by condensation with isoniazid, furnished the corresponding isatin–isoniazid hydrazone-based alkyne intermediate. Subsequent CuAAC reaction with a series of aromatic azides afforded a library of 1,2,3-triazole derivatives incorporating isatin–isoniazid hydrazone conjugates. The synthesized click adducts were characterized using the appropriate spectroscopic techniques, including 1H, 13C, and 19F NMR, and HRMS. They were also subjected to dual EGFR/PARP-1 inhibition and cytotoxic screening in MDA-MB-231 TNBC cells, and apoptosis induction was assessed by flow cytometry and RT-PCR. Compounds 9, 10, and 11 exhibited IC50 values of 93, 64, and 78 nM, respectively, compared to Erlotinib (IC50 = 80 nM); they exhibited IC50 values of 76, 12, and 28 nM, respectively, compared to Olaparib (IC50 = 12 nM). They showed potent cytotoxicity against MDA-MB-231 cells with IC50 values of 16.3±0.4, 1.27±0.1, and 3.46±0.1 μM, respectively. However, when tested against normal MCF-10A cells, they showed low cytotoxicity and greater IC50 values. The cell cycle was halted at the G2-phase by compound 10, which promoted apoptosis 7.16-fold. The MDA-MB-231 cancer cells' apoptosis-related genes were impacted. Molecular docking analysis revealed good binding disposition of compound 10 to the two EGFR/PARP-1 target proteins.

